Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Artificial Cells, Nanomedicine and Biotechnology is Scopus-indexed (Q1, CiteScore 8.5), WoS SCIE, DOAJ. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 2169-1401Verify ISSN ↗2169-141XVerify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (miscellaneous) | 53 / 466 | 88th | Q1 |
| Pharmaceutical Science | 35 / 191 | 81st | Q1 |
| Biotechnology | 75 / 325 | 77th | Q1 |
| Biomedical Engineering | 79 / 342 | 77th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2013–present, best quartile Q1, CiteScore 8.5.
Artificial Cells, Nanomedicine and Biotechnology is Q1 in Medicine (miscellaneous) (rank 53 of 466), Q1 in Pharmaceutical Science (rank 35 of 191) and Q1 in Biotechnology (rank 75 of 325), by CiteScore 2025. It is ranked in 4 subject areas in all.
Artificial Cells, Nanomedicine and Biotechnology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 8.5, which places it in quartile Q1 at the 88th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.967, quartile Q1, with an H-index of 105.
The publisher lists an article processing charge of about US$2,557 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Artificial Cells, Nanomedicine and Biotechnology is published by Taylor and Francis Ltd. Its print ISSN is 2169-1401 and its online ISSN is 2169-141X.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Artificial Cells, Nanomedicine and Biotechnology has an h-index of 114 and a 2-year mean of 4.65 citations per paper (OpenAlex). Its Scopus CiteScore is 8.5, quartile Q1. On 2-year citations it ranks #55 of 451 Scopus journals in Medicine (miscellaneous).
Artificial Cells, Nanomedicine and Biotechnology published 54 papers in 2025; its busiest recent year was 2019 with 521. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2024–2026), authors are most often from China (31.1%), United States (7.9%) and India (7.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 214 retracted papers are recorded (92.8 per 1,000 papers). The Problematic Paper Screener flags 6 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.